[Treatment of symptomatic prostatic hypertrophy with the KTP-80 laser].
Macroscopic per and post-operative hematuria contributes significantly to hospitalisation time and to the morbidity of conventional surgery of symptomatic prostatic hypertrophy. It requires in fact transient anti-coagulation interruption, so as eventually a window with platelet anti-agregants. The newly available 80-Watts Potassium-Titanyl-Phosphate laser markedly reduces post-operative hematuria, and allows operating the increasing population of patients under platelet anti-agregants, or event those who need therapeutic anticoagulation. This series reports on our initial experience with a technique which decreases remarkably post-operative catheterization and hospitalisation time, and whose obstruction relief is efficient, but needs to stand the test of time.
Fateri
Farchid
F
Service d'urologie, Département de chirurgie, HUG, 1211 Genève 14. Farchid.Fateri@hcuge.ch
Caviezel
Alessandro
A
Saaidia
Abdelkader
A
Iselin
Christophe
C
D006417:Hematuria / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D011183:Postoperative Complications; D011470:Prostatic Hyperplasia / Q000601:surgery*; D016896:Treatment Outcome; D014546:Urinary Catheterization